Not applicableStudy completedNCT02740153What this trial is testingPCORI Urea Cycle Disorder StudyWho this might be right forUrea Cycle Disorders Children's National Research Institute 187
Testing effectiveness (Phase 2)WithdrawnNCT01791192What this trial is testingStudy of FTY720 in Patients With UveitisWho this might be right forAcute Noninfectious Posterior, Intermediate, or Pan Uveitis Novartis Pharmaceuticals
Not applicableLooking for participantsNCT05299710What this trial is testingOvarian Tissue Cryopreservation in Pre-Pubertal (OTC-Pre Pubertal)Who this might be right forCancers Erin Rowell 250
Post-approval studies (Phase 4)Study completedNCT03335488What this trial is testingStudy of Glycerol Phenylbutyrate & Sodium Phenylbutyrate in Phenylbutyrate Naïve Patients With Urea Cycle Disorders (UCDs)Who this might be right forUrea Cycle Disorder Amgen 16
Post-approval studies (Phase 4)Study completedNCT01742507What this trial is testingA Study Comparing Two Stent on the Degree of Early Stent Healing and Late Lumen Loss.The OCT-ORION StudyWho this might be right forCoronary Artery Disease The University of Hong Kong 60
Testing effectiveness (Phase 2)Study completedNCT02488044What this trial is testingAEB1102 in Patients With Arginase I DeficiencyWho this might be right forArginase I DeficiencyHyperargininemia Aeglea Biotherapeutics 16
Early research (Phase 1)Not Yet RecruitingNCT06735638What this trial is testingOutside the Cage (OTC) Robotic EsophagectomyWho this might be right forEsophageal Cancer Centre hospitalier de l'Université de Montréal (CHUM) 31
Not applicableStudy completedNCT05706714What this trial is testingTh1, Th2, Th17 Phenotype in Urea Cycle DisordersWho this might be right forUrea Cycle DisorderLysinuric Protein Intolerance Istanbul University - Cerrahpasa 65
Not applicableUnknownNCT05301218What this trial is testingCAlcified Lesion Intervention Planning Steered by OCT.Who this might be right forCoronary Artery CalcificationAngioplasty Institut Mutualiste Montsouris 140
Large-scale testing (Phase 3)Study completedNCT03921541What this trial is testingEfficacy and Safety of Pegzilarginase in Patients With Arginase 1 DeficiencyWho this might be right forArginase I DeficiencyHyperargininemia Immedica Pharma AB 32
Not applicableUnknownNCT00237315What this trial is testingLongitudinal Study of Urea Cycle DisordersWho this might be right forBrain Diseases, Metabolic, InbornAmino Acid Metabolism, Inborn ErrorsUrea Cycle Disorders Andrea Gropman 1,500
Early research (Phase 1)Study completedNCT04416126What this trial is testingSafety, Tolerability and Pharmacokinetics of ARCT-810 in Healthy Adult SubjectsWho this might be right forOrnithine Transcarbamylase Deficiency Arcturus Therapeutics, Inc. 30
Large-scale testing (Phase 3)Active Not RecruitingNCT05345171What this trial is testingClinical Study of DTX301 AAV-Mediated Gene Transfer for Ornithine Transcarbamylase (OTC) DeficiencyWho this might be right forOTC Deficiency Ultragenyx Pharmaceutical Inc 37
Not applicableStudy completedNCT04444037What this trial is testingImpact of OCT Imaging on Decision Making During PCI in ACS PatientsWho this might be right forAcute Coronary Syndrome Assiut University 390
Not applicableLooking for participantsNCT06953505What this trial is testingAt Home Ammonia Monitoring of Inborn Errors of Ammonia MetabolismWho this might be right forUrea Cycle DisordersOrganic AcidemiasFatty Acid Oxidation Disorder+1 more Sequitur Health Corp. 30
Not applicableStudy completedNCT03323307What this trial is testingLow Cost OCT for Point of CareWho this might be right forOptical Coherence Tomography (OCT) of the Retina Duke University 70
Not applicableStudy completedNCT02124330What this trial is testingProtein Sorbent Properties of Montmorillonite in Vitro and in Vivo ModelsWho this might be right forUrea Cycle Disorders, InbornOther Metabolic Diseases Luca Ronfani 35
Post-approval studies (Phase 4)Study completedNCT01257737What this trial is testingTo Evaluate the Safety of Long-term Use of HPN-100 in the Management of Urea Cycle Disorders (UCDs)Who this might be right forUrea Cycle Disorders Amgen 88
Early research (Phase 1)Study completedNCT00986895What this trial is testingGlyceryl Tri-(4-phenylbutyrate) Administered Orally as a Single Dose, and Twice Daily for Seven Consecutive Days to Subjects With Hepatic Impairment With Cirrhosis and to a Control GroupWho this might be right forHepatic EncephalopathyUrea Cycle Disorders Amgen 32
Testing effectiveness (Phase 2)Ended earlyNCT03181828What this trial is testingManipulating the Gut Microbiome StudyWho this might be right forUrea Cycle Disorder Nicholas Ah Mew 4